Thilde Terkelsen

Thilde Terkelsen

Auto-generated profile, based on publicly available information

Thilde Terkelsen

Center for Health Data Science, University of Copenhagen, Copenhagen, Denmark

Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
24 March 2023 in Gastroenterology
Verified
Journal Article
Open access
JBJacob Mathias Bech
Jacob Mathias Bech
TTThilde Terkelsen
Thilde Terkelsen
ABAnnette Snejbjerg Bartels
Annette Snejbjerg Bartels
FCFabian Coscia
Fabian Coscia
SDSophia Doll
Sophia Doll
Jose MoreiraJose Moreira
Jose Moreira
Colonic adenomatous polyps, or adenomas, are frequent precancerous lesions and the origin of most cases of colorectal adenocarcinoma. However, we know from epidemiologic studies that although most colorectal cancers (CRCs) originate from adenomas, only a small fraction of adenomas (3%-5%) ever progress to cancer. At present, there are no molecular markers to guide follow-up surveillance programs. We profiled, by mass spectrometry-based proteomics combined with machine learning analysis, a selected cohort of formalin-fixed, paraffin-embedded high-grade (HG) adenomas with long clinical follow-up, collected as part of the Danish national screening program. We grouped subjects in the cohort according to their subsequent history of findings: a nonmetachronous advanced neoplasia group (G0), with no new HG adenomas or CRCs up to 10 years after polypectomy, and a metachronous advanced neoplasia group (G1) where individuals developed a new HG adenoma or CRC within 5 years of diagnosis. We generated a proteome dataset from 98 selected HG adenoma samples, including 20 technical replicates, of which 45 samples belonged to the nonmetachronous advanced neoplasia group and 53 to the metachronous advanced neoplasia group. The clear distinction of these 2 groups seen in a uniform manifold approximation and projection plot indicated that the information contained within the abundance of the ∼5000 proteins was sufficient to predict the future occurrence of HG adenomas or development of CRC. We performed an in-depth analysis of quantitative proteomic data from 98 resected adenoma samples using various novel algorithms and statistical packages and found that their proteome can predict development of metachronous advanced lesions and progression several years in advance.

10 May 2024 in Gut Microbes
Verified
Journal Article
Open access
Lasse Andersson KvichLasse Andersson Kvich
Lasse Andersson Kvich
BFBlaine Gabriel Fritz
Blaine Gabriel Fritz
HZHenrike Zschach
Henrike Zschach
TTThilde Terkelsen
Thilde Terkelsen
HRHans Henrik Raskov
Hans Henrik Raskov
TBThomas Bjarnsholt
Thomas Bjarnsholt
Extensive research has explored the role of gut microbiota in colorectal cancer (CRC). Nonetheless, metatranscriptomic studies investigating the in situ functional implications of host-microbe interactions in CRC are scarce. Therefore, we characterized the influence of CRC core pathogens and biofilms on the tumor microenvironment (TME) in 40 CRC, paired normal, and healthy tissue biopsies using fluorescence in situ hybridization (FISH) and dual-RNA sequencing. FISH revealed that Fusobacterium spp. was associated with increased bacterial biomass and inflammatory response in CRC samples. Dual-RNA sequencing demonstrated increased expression of pro-inflammatory cytokines, defensins, matrix-metalloproteases, and immunomodulatory factors in CRC samples with high bacterial activity. In addition, bacterial activity correlated with the infiltration of several immune cell subtypes, including M2 macrophages and regulatory T-cells in CRC samples. Specifically, Bacteroides fragilis and Fusobacterium nucleatum correlated with the infiltration of neutrophils and CD4+ T-cells, respectively. The collective bacterial activity/biomass appeared to exert a more significant influence on the TME than core pathogens, underscoring the intricate interplay between gut microbiota and CRC. These results emphasize how biofilms and core pathogens shape the immune phenotype and TME in CRC while highlighting the need to extend the bacterial scope beyond CRC pathogens to advance our understanding and identify treatment targets.

27 October 2021 in Proceedings Of The Royal Society B-Biological Sciences
Verified
Journal Article
Open access
Iben StokholmIben Stokholm
Iben Stokholm
WPWendy Puryear
Wendy Puryear
KSKaitlin Sawatzki
Kaitlin Sawatzki
SKSteen Wilhelm Knudsen
Steen Wilhelm Knudsen
TTThilde Terkelsen
Thilde Terkelsen
MOMorten Tange Olsen
Morten Tange Olsen
Canine distemper virus (CDV) and phocine distemper virus (PDV) are major pathogens to terrestrial and marine mammals. Yet little is known about the timing and geographical origin of distemper viruses and to what extent it was influenced by environmental change and human activities. To address this, we (i) performed the first comprehensive time-calibrated phylogenetic analysis of the two distemper viruses, (ii) mapped distemper antibody and virus detection data from marine mammals collected between 1972 and 2018, and (iii) compiled historical reports on distemper dating back to the eighteenth century. We find that CDV and PDV diverged in the early seventeenth century. Modern CDV strains last shared a common ancestor in the nineteenth century with a marked radiation during the 1930s–1950s. Modern PDV strains are of more recent origin, diverging in the 1970s–1980s. Based on the compiled information on distemper distribution, the diverse host range of CDV and basal phylogenetic placement of terrestrial morbilliviruses, we hypothesize a terrestrial CDV-like ancestor giving rise to PDV in the North Atlantic. Moreover, given the estimated timing of distemper origin and radiation, we hypothesize a prominent role of environmental change such as the Little Ice Age, and human activities like globalization and war in distemper virus evolution.

20 October 2023 in bioRxiv
Verified
Preprint
Open access
PDF file
Lasse Andersson KvichLasse Andersson Kvich
Lasse Andersson Kvich
BFBlaine Gabriel Fritz
Blaine Gabriel Fritz
HZHenrike Zschach
Henrike Zschach
TTThilde Terkelsen
Thilde Terkelsen
HRHans Henrik Raskov
Hans Henrik Raskov
TBThomas Bjarnsholt
Thomas Bjarnsholt
Objective: Growing evidence links bacterial dysbiosis with colorectal cancer (CRC) carcinogenesis, characterized by an increased presence of core pathogens such as Bacteroides fragilis and Fusobacterium nucleatum . Here, we characterized the in situ biogeography and transcriptional interactions between bacteria and the host in mucosal colon biopsies. Design: The influence of CRC core pathogens and biofilms on the tumour microenvironment (TME) was investigated in biopsies from patients with and without CRC (paired normal tissue and healthy tissue biopsies) using fluorescence in situ hybridization and dual-RNA sequencing. Results: Tissue-invasive, mixed-species biofilms enriched for B. fragilis and F. nucleatum were observed in CRC tissue, especially in right-sided tumours. Fusobacterium spp. was associated with increased bacterial biomass and inflammatory response in CRC samples. CRC samples with high bacterial activity demonstrated increased expression of pro-inflammatory cytokines, defensins, matrix-metalloproteases, and immunomodulatory factors. In contrast, the gene expression profiles of CRC samples with low bacterial activity resembled healthy tissue samples. Moreover, immune cell profiling showed that B. fragilis and F. nucleatum modulated the TME and correlated with increased infiltration of neutrophils and CD4 + T-cells. Overall, bacterial activity was critical for the immune phenotype and correlated with the infiltration of several immune cell subtypes, including M2 macrophages and regulatory T-cells. Conclusion: Biofilms and core pathogens shape the TME and immune phenotype in CRC. Our results support that Fusobacterium spp . may provide a future therapeutic target to reduce biofilms and the inflammatory response in the TME while highlighting the importance of widening the scope of bacterial pathogenesis in CRC beyond core pathogens.

28 January 2023 in bioRxiv
Verified
Preprint
Open access
PDF file
IPInigo Prada-Luengo
Inigo Prada-Luengo
VSViktoria Schuster
Viktoria Schuster
YLYuhu Liang
Yuhu Liang
TTThilde Terkelsen
Thilde Terkelsen
VSValentina Sora
Valentina Sora
AKAnders Krogh
Anders Krogh
Differential gene expression analysis of bulk RNA sequencing data plays a major role in the diagnosis, prognosis, and understanding of disease. Such analyses are often challenging due to a lack of good controls and the heterogeneous nature of the samples. Here, we present a deep generative model that can replace control samples. The model is trained on RNA-seq data from healthy tissues and learns a low-dimensional representation that clusters tissues very well without supervision. When applied to cancer samples, the model accurately identifies representations close to the tissue of origin. We interpret these inferred representations as the closest normal to the disease samples and use the resulting count distributions to perform differential expression analysis of single cancer samples without control samples. In a detailed analysis of breast cancer, we demonstrate how our approach finds subtype-specific cancer driver and marker genes with high specificity and greatly outperforms the state-of-the-art method in detecting differentially expressed genes, DESeq2. We further show that the significant genes found using the model are highly enriched within cancer-specific driver genes across different cancer types. Our results show that the in silico closest normal provides a more favorable comparison than control samples.